Works matching IS 10031057 AND DT 2024 AND VI 33 AND IP 1

Results: 11

The 2024 Seminar on the Development of Pharmaceutical Formulations & Academic Annual Meeting of Beijing Key Laboratory of Molecular Pharmacy and New Drug Delivery Systems was successfully held in Beijing.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 1, p. 77
Publication type:: Article

The team of Prof. Luwen Shi and Prof. Xiaodong Guan made research progress in different restriction level adjustments on antibiotic use in China.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 1, p. 74
Publication type:: Article

Prof. Xinshan Ye and Prof. Suwei Dong won the Hui Yongzheng Glycoscience Award.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 1, p. 72
Publication type:: Article

The team of Prof. Luwen Shi and Prof. Xiaodong Guan made progress in randomized clinical trials of investigational cancer drugs in China.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 1, p. 69
Publication type:: Article

Medication analysis and pharmacy service for a patient with heart failure in ischemic cardiomyopathy combined with appendage thrombosis.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 1, p. 63, doi. 10.5246/jcps.2024.01.007

By:

Ye Yuan;
Zhenzhen Yang;
Bo Yu;
Xiuling Yang

Publication type:

Article

Generic development and market exclusivity period in China: an analysis from 2003 to 2020.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 1, p. 57, doi. 10.5246/jcps.2024.01.006

By:

Congya Zhou;
Tao Huang;
Jiahui Gu;
Huangqianyu Li;
Luwen Shi;
Xiaodong Guan

Publication type:

Article

Study on the dose-effect relationship and mechanism of reactive oxygen species promoted neuroprotection.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 1, p. 46, doi. 10.5246/jcps.2024.01.005

By:

Rong Huang;
Xiaojiao Hu;
Runfang Zhang;
Xiaohui Li;
Juan Cen

Publication type:

Article

Exploring irinotecan adverse reactions in the real world: a study on UGT1A1 heterozygous mutations.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 1, p. 35, doi. 10.5246/jcps.2024.01.004

By:

Jing Zuo;
Jun Meng;
Chao Li;
Zhengzheng Xia;
Haochun Tang;
Anna Li;
Xiaofu Ma

Publication type:

Article

A comprehensive comparative analysis of transfection reagents for siRNA delivery.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 1, p. 26, doi. 10.5246/jcps.2024.01.003

By:

Shuwen Tong;
Xianrong Qi

Publication type:

Article

Design, synthesis, and biological assessment of prodrugs for nitroreductase-based HSP90 inhibitor BIIB021: exploring their potential as anticancer agents.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 1, p. 15, doi. 10.5246/jcps.2024.01.002

By:

Zhengrong Wu;
Qinjian Xie;
Peng Jing;
Tianfeng Zhang;
Jiaxi Han;
Dian He

Publication type:

Article

Design, synthesis, and biological evaluation of covalent inhibitors targeting influenza virus hemagglutinin.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 1, p. 1, doi. 10.5246/jcps.2024.01.001

By:

Nian Wang;
Chenning Li;
Chenxi Cheng;
Jianzhong Chen;
Pengfei Wang;
Xun Lv;
Xuebing Li

Publication type:

Article